Vaxess Technologies, Inc

Bronze Sponsor

Vaxess is a clinical-stage company bringing healthcare out of the clinic and into patients’ lives with the shelf-stable, self-applied MIMIX patch platform. The company has a pipeline of vaccines and biologics under development, including the first influenza vaccine intended for home-based administration. Vaxess is headquartered in Cambridge, MA and has a GMP manufacturing facility in Woburn, MA. The company has raised more than $60M in grant and VC funding from groups such as RA Capital, The MIT Engine, BARDA, DARPA, NIH, NSF, and The Gates Foundation.